Patient variability in nutritional case reports
Authors:
Věra Boháčová; Tamara Starnovská
Authors place of work:
Fórum zdravé výživy, Sekce výživy a nutriční péče, z. s., Praha
Published in the journal:
AtheroRev 2020; 5(3): 173-175
Category:
Summary
Nutritional and regime recommendations within the primary and secondary prevention of dyslipidemias (and cardiovascular diseases) have their specifics. However, their observance is significantly affected by several factors. These can include the individual possibilities of the patient (financial, logistical), the presence or absence of comorbidities, the very approach of patients. All these specifics must be considered in the recommendations. The interpretation of the same nutritional and regime recommendations may then take different forms in different patients. In practice, we meet patients who downplay their illnesses (“nothing hurts, nothing needs to be changed”), who prefer to follow everything more strictly without realizing the risk of nutritional delays, prepare for education and know in advance about they read everything to the diet or gather advice in their surroundings. However, such advice is not always shared with expert opinions. And then, of course, even those who are willing to make changes for the better in their lives and they can keep them for a long time. The nutritionist must be able to respond to all these individual specifics and interpret the recommendations according to them.
Keywords:
dyslipidemias – patient – recommendations – regime measures – special diet
Zdroje
- Češka R, Herber O, Vrablík M et al. [Společnost všeobecného lékařství]. Dyslipidémie. Doporučené diagnostické a terapeutické postupy pro všeobecné praktické lékaře 2017. Centrum doporučených postupů pro praktické lékaře – Společnost všeobecného lékařství; Praha 2017. ISBN 978–80–86998–89–3. Dostupné z WWW: <https://www.svl.cz/files/files/Doporucene-postupy/2017/DP-Dyslipidemie.pdf>.
- Vrablík M, Piťha J, Bláha V et al. Stanovisko výboru České společnosti pro aterosklerózu k doporučením ESC/EAS pro diagnostiku a léčbu dyslipidemií z roku 2019. AtheroRev 2019; 4(3): 19–30.
- Mach F, Baigent C, Catapano AL et al. [Authors/Task Force Members; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies]. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Atherosclerosis 2019; 290:140–205. Dostupné z DOI: <https://doi.org/10.1016/j.atherosclerosis.2019.08.014>.
- Dostálová J, Dlouhý P, Tláskal P et. al. [Společnost pro výživu]. Výživová doporučení pro obyvatelstvo ČR. Společnost pro výživu 2012. Dostupné z WWW: <http://www.vyzivaspol.cz/vyzivova-doporuceni-pro-obyvatelstvo-ceske-republiky/>.
Štítky
Angiology Diabetology Internal medicine Cardiology General practitioner for adultsČlánok vyšiel v časopise
Athero Review
2020 Číslo 3
- Memantine Eases Daily Life for Patients and Caregivers
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Metamizole vs. Tramadol in Postoperative Analgesia
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Spasmolytic Effect of Metamizole
Najčítanejšie v tomto čísle
- Hypertriglyceridemia – today and tomorrow
- Genetic testing of familial hypercholesterolemia in clinical practice: statement of Czech Society for Atherosclerosis
- GLP-1 receptor agonists: antidiabetic agents with antiatherogenic effect
- Mendelian randomisation studies: principle and selected examples from cardiovascular medicine